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ABSTRACT 
Bilayer tablet is a successful technology of controlled release formulation or extended release formulation to provide successful drug delivery. 
The name of this development is clear that the tablets have been consisting of two layers, these are immediate release layer (IR) and another is 
extended release layer (ER). In this era it is very useful in many developing countries as a combination therapy for various disease treatment 
purposes. Bilayer tablet are needs to separate incompatible active pharmaceutical ingredients (API) by physical separation. In this formulation 
IR and ER both layers are present and it form extended release layer (ER). This types of formulations helps to maintain plasma level 
concentration in the body. So, it is a very useful and successful technology in novel drug delivery system.  
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Bilayer tablet is the technology used for extended or 
sustained release formulation. It is developed by 
combination of two or more active pharmaceutical 
ingredients in a single dosage form which makes compatible 
dosage form. In bilayer tablet there one layer is immediate 
release and another is extended release layer. This 
technology also helps to avoid chemical incompatibilities 
between different APIs by physical separation.  
This technology is developed in order to achieve modified 
release of a drug. In case of conventional dosage forms, there 
will be a wide range of fluctuations in the drug 
concentration, which shows unwanted toxicity & low 
efficiency [1]. 
Advantages  
 This technology helps to avoid chemical incompatibility 
between different API’s by physical separation. 
 It helps to avoid the repetitive dosage form.  
  Suitable for sequential release of two drugs [1]. 
 Treat the co-morbidity at the same time with one pill.  
 In this technology drugs are choose on their synergistic 
effect.  
 It maintains the plasma concentration because IR and 
ER both layers are present. 
  Easy to swallow [2]. 
 It helps to provide physical, chemical, microbial 
stability than other type formulation. 
 It is an extension of conventional technology. 
Disadvantages [4] 
 The size of this type of tablets is bigger than another 
formulation. So, it is difficult to swallow for children 
and sometimes for unconscious people.  
 Low yield, insufficient hardness &the layers gets 
separated. 
 There is a chance of cross contamination between two 
layer.  
Need of bilayer tablets [5] 
 It maintain the prolong drug product life cycle because 
of administration of fixed dose combination of API.  
 Controlling the delivery rate of either single or two 
different active pharmaceutical ingredients.  
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 To modify the total surface area available for API layer 
either by sandwiching with one or two inactive layer in 
order to achieve swellable or erodible barriers for 
modified release.  
Tablet press: A tablet press is a mechanical devices that 
compress powder into tablet of uniform size and weight. A 
tablet press can be used to manufacture tablets of wide 
variety of materials, including pharmaceuticals, 
neutraceuticals, clinic product and cosmetics. To form a 
tablets the granulated materials must be metered into a 
cavity formed by two punches and die, then the punches 
must be pressed together with great force to fused and the 
material together [11]. 
Types of bilayer tablet press [4] 
I. Single sided tablet press  
II. Double sided tablet press 
III. Bilayer tablet press with displacement monitoring  
Single sides press 
This is the simplest design which is a single sided press with 
both chambers and double feeder separated from each other. 
Each chamber is forced fed with different powers, thus 
producing the two individual layers of the tablets. When the 
die passes under the feeder, it is at first loaded with the first 
layer powder followed by the second layer powder. Then the 
entire tablet is compressed in one or two steps.  
No weight control of different layer. 
It is very difficult first layer for tablet sampling to a test unit 
in quality control.  
It is difficult for separation of two individual layer by visual 
observation if there is no colour in between two layer.  
Double sided tablet press 
Most double sided tablet presses with automated production 
control use compression force to control tablet weight. The 
effective peak (Dwell time) compression force exerted on 
each individual tablet or layer is measured by the control 
system at the main compression of the layer. The limitations 
of single sided press are overcome in double sided tablet 
press. 
The 2 individual layers are separated because of insufficient 
bonding between them during final stage of compression. 
Because of low compression force the first layer is interact 
with second layer. 
Bilayer tablet displacement with monitoring  
Displacement tablet weight control is based upon the tablet 
compression force. We can alternate the compression force 
measurement by displacement measurement. If we measure 
the displacement the control system not depends on the 
tablet weight but depends on the pre compression force of 
tablet. It provide the high accuracy by reducing the 
compression force. Because of the low compression for we 
can avoid capping problem and get sufficient hardness with 
maximum turret speed. 
Bilayer tablets: Quality and GMP requirements:  
To procedure a quality bilayer, in a validated and GMP-way it 
is important that the selected press is capable of preventing 
capping and separation of the two individual layers that 
constitute the bilayer tablet. Providing sufficient tablet 
hardness. Preventing cross contamination between two 
layers. High yield. Accurate and individual weight controls 
the two layers [12]. 
Dose calculation of bilayer tablet 
For immediate release layer the equation is  
DIR = Cp * Vd/F     ( Where Cp is target serum level, Vd is 
volume of distribution, F is bioavailability factor)  
For extended release layer the equation is  
DSR = DIR (1+ 0.693* t/t1/2)     ( where t is the time in hour for 
which the ER of the drug is desire, t1/2 is half-life of drug) 
Extended Release Drug Delivery System[9] 
The extended release drug delivery system is a novel 
approach of modified release of drug delivery. Extended 
release means a dosage form which allows to reduction in 
dose frequency of two fold as compare to immediate release. 
The extended release dosage form is included controlled 
release, sustained release, prolong release form etc.  
Advantages:  
1. It helps to reduce the dosing frequency of drug.  
2. This conventional dosage form helps to less fluctuation 
of drug in blood vessels.  
3. This helps to maintain the plasma therapeutic index 
means maintain the minimum effective concentration.  
4. It helps to improve the poor patient compliance.  
5. Helps to improve the treatment efficacy.  
6. In this formulation drugs are absorbed and released 
slowly. So, it shows less toxicity.  
7. Helps to improve the bioavailability of some drugs.  
Disadvantages:  
1. There is a chance of dose dumping.  
2. The larger size of extended release formulation may 
cause difficulties to swallow or transit through GI tract.  
3. It may increase potential for fast pass metabolism.  
4. It can decrease the systemic bioavailability than 
immediate release dosage form.  
5. The production cost is high of this formulation.  
Methods:  
Various techniques are used to formulate the extend release 
formulation. ER formulations are divided into different 
categories based on their mechanism of drug release.  
I. Diffusion system  
II. Dissolution system  
III. Osmotic system 
IV. Ion-exchange resin system 
Diffusion system:  
Diffusion means the molecules goes to high density to low 
density area or media. This system depends on the rate 
where drug dissolves through a barrier (polymer). Diffusion 
controlled system is mainly two types:  
a. Matrix system: The matrix devices form a matrix 
which consists of active and inactive ingredients and 
where drug is dissolved or dispersed. The rate of 
dissolution of the drug within matrix need to be higher 
than the rate when it is release. It cannot follow the 
zero order release but govern by Fick’s 1st law of 
diffusion.  
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b. Reservoir system: This system consists of core or 
reservoir and coating membrane or diffusion barrier. In 
this system the drug is surrounded by polymeric 
membrane. The polymer must not dissolve and the 
drug release through diffusion system.  
Dissolution system: It is a system where dosage forms are 
dissolved slowly in order for drug to have sustained release 
property. It is mainly used for those types of drug which are 
highly soluble in water. The rate of dissolution and amount 
of per unit time is calculated by Noyes- Whitney equation. 
The equation is as follow –  
dW/dtL = DA ( Cs – C)  
where, dW/dt = rate of dissolution;  
A = surface area of the solidification;  
C = concentration of the solid in the bulk dissolution 
medium;  
Cs = concentration of solid in the diffusion layer surrounding 
the solid;  
D = diffusion coefficient and  
L = diffusion layer thickness. 
Osmotic system: These types of delivery system there form 
of rigid tablet with a semipermeable outer membrane. When 
tablet passes through the body the water is absorbed 
through the membrane by osmosis process. The membrane 
consists of one or more small drilled whole. When water is 
absorbed in the tablet then osmotic pressure is formed to 
push the active ingredients comes out from the tablet. This 
system less affected by pH, food habit, GI motility etc.  
Ion-Exchange resin system: Ion exchange resins are cross-
linked water insoluble polymers that contain insoluble 
functional group. In tablet formulation ion-exchange resins 
are mostly used as disintegrant because of their swelling 
ability. The drug is attached to the resin. It is released after 
interaction of ions and ion exchange groups occur.  
Bilayer tablet: Use as a Extended release formulation  
Modified release dosage is a mechanism that (in contrast to 
immediate release dosage) deliver a drug with a delay after 
its administration (delayed release dosage) or for a prolong 
period of time (extended release [ER] dosage) or to specific 
target in the body (target release dosage). 
Extended release dosage consists of either sustained release 
(SR) or controlled release (CR) dosage. SR maintains drug 
release over a sustained period of time but rate is not 
constant. But for CR the rate nearly constant. 
 
 
Figure 1: Plasma Concentrations 
The immediate release layer reach the therapeutic level in 
plasma within shortest period. After this when extended 
release layer release the drug then it will maintain the 
plasma straight line in plasma concentration in body. The 
graphical representation will be cleared the plasma 
concentration of drug in body. 
Evaluation of Bilayer tablet  
Particle size distribution: Sieving is used to determine 
particle size distribution. From  
Angle of repose:  Angle of repose was calculated by 
measuring the diameter and height  of the powder cone.  
               Tan θ=h/r  
Where “r” is the radius and “h” is height of the powder cone. 
Bulk Density [7]: The powder is weighed accurately and 
poured into the graduated cylinder without any disturbance. 
Then the volume is marked.  
Bulk Density = Weight of Powder / Bulk volume 
Tapped density: After measuring the bulk density the 
cylinder is kept in tap density apparatus for checking the 
tapped density. The tapped density apparatus is operated for 
500 taps. After this we should check the volume. If it is 
greater than 2ml then again it is kept for 750 tapping and 
after this check the weight.  
Tapped density = Weight of powder / Tapped volume 
Carr’s Index: Compressibility index = Dt – Db / Dt *100 
Where Dt is tapped density and Db is bulk density. 
Hausner’s Ratio: Low Hausner’s ratio means that the drug 
has high Flowability. It was calculated using equation given 
below. 
Hausner’s ratio = Tapped density/ Bulk density 
Table 2: Compressibility Index limit 
Carr’s Index Flow Character  Hausner’s Ratio 
1 – 10 Excellent  1.00-1.11 
11 – 15 Good  1.12 – 1.18 
16 – 20 Fair  1.19 – 1.25 
21 – 25 Passable  1.26 – 1.34 
26 – 31 Poor  1.35 – 1.45 
32 – 37 Very poor 1.46 – 1.59 
˃ 38 Very very poor ˃ 1.60 
 
Thickness and Hardness: These are important parameters 
for tablet evaluation. The thickness and size is measured by 
vernire calipers. The hardness is measured by Monsanto 
hardness tester or Pfizer hardness tester.  
Friability: It is used to measure the mechanical strength of 
the tablet or granules. The equipment used for determining 
friability is friabilator. 10-20 tablets are accurately weighed 
or tablet weight having 650mg and placed in the Rochy 
friabilator which revolves at 25rpm by dropping the tablets 
from a height of 6 inch in each revolution. Tablets are then 
weighed after 4mins or 100 times rotation. If it is necessary 
then sometimes process is continued for 300 times rotation. 
% Friability = (loss of weight / initial weight) *100 
Acceptance Criteria of % Friability:  
For uncoated tablet it is not more than 1%.  
For conventional compressed tablets it should be within 
0.5% - 1%.  
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Weight variation: 20 tablets (not less than 10) are collected 
randomly and checked individual weight by electronic 
balance. The average weight and standard deviation of 20 
tablets are calculated. After this we can decide it is passed or 
not compare with standard value which is shown in the 
table. 
 
Avg. weight of tablets as per IP/BP Limit Avg. weight of tablets as per USP 
80mg or less ±10% 130mg or less 
More than 80mg or less than 250mg ±7.5% 130mg to 324mg 
250mg or more ±5% More than 325mg 
 
In-vitro dissolution study : Tablets are subjected to in vitro 
drug dissolution studies in simulated gastric & intestinal 
fluid to evaluate the controlled drug delivery potential. This 
is done by mostly USP II paddle type apparatus. There 
maintain the rpm 75-100 and temperature 37oC±2oC. 
Dissolution study is carried by pH 1.2 buffer for 1-2 hours 
and pH 6.8 buffer for minimum 10 hours because there 
present both immediate and extended release layer. Then 
samples are analysed by UV spectrophotometer. 
Conclusion  
Bilayer tablet is a technology which is beneficial for patient 
and excellent opportunity for manufacturer which make 
separate then others or competitors. Bilayer tablet consists 
of two layer where one is immediate release and another is 
extended release layer. So, the IR drug reach high serum 
concentration in a short period of time and ER layer maintain 
the an effective plasma level for prolong period of time. So, it 
maintain the straight line in zero order kinetics in plasma 
and maintain therapeutic concentration. So, now a days 
bilayer tablets are prepared such as “Sitagliptin, Metformin 
HCl”, “Atorvastatin, Atenolol” etc. in market. 
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